10/06/2025
7:17 AM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2025
3:30 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2025
3:57 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2025
3:09 PM | Gilead Sciences (Subject)
O'Day Daniel Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2025
6:53 PM | Burkhart Erin (Reporting)
Gilead Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/23/2025
6:55 PM | Burkhart Erin (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
4:12 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2025
4:16 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2025
3:38 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/15/2025
3:04 PM | Gilead Sciences (Subject)
Mercier Johanna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2025
6:31 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GILD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. |
09/11/2025
6:34 PM | Gilead Sciences (Issuer)
Wilfong Diane E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2025
6:38 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2025
5:31 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2025
5:28 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2025
3:16 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2025
9:09 AM | Gilead Sciences (Filer)
| Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company | |
08/28/2025
3:47 PM | Gilead Sciences (Subject)
O'Day Daniel Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2025
7:56 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
6:34 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
3:08 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
9:58 AM | Gilead Sciences (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
08/12/2025
3:30 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
07/28/2025
3:36 PM | Gilead Sciences (Subject)
O'Day Daniel Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2025
4:41 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
4:45 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2025
6:46 PM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
07/14/2025
3:01 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
5:02 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2025
3:05 PM | Gilead Sciences (Subject)
O'Day Daniel Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2025
5:04 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
5:08 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
5:55 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
5:58 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:01 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
6:10 PM | Gilead Sciences (Issuer)
Wilfong Diane E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
5:52 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
6:31 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
7:55 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
3:16 PM | Gilead Sciences (Subject)
O'Day Daniel Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2025
2:16 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/13/2025
10:44 AM | Capital World Investors (Filed by)
Gilead Sciences (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
7:16 PM | Bluestone Jeffrey (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:17 PM | Gilead Sciences (Issuer)
Kramer Kelly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:18 PM | Gilead Sciences (Issuer)
MANWANI HARISH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:26 PM | Gilead Sciences (Issuer)
Horning Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:20 PM | BARTON JACQUELINE K (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:22 PM | Gilead Sciences (Issuer)
LOVE TED W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:25 PM | Gilead Sciences (Issuer)
Rodriguez Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
5:27 PM | Gilead Sciences (Issuer)
WELTERS ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
4:26 PM | Gilead Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
12:24 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
8:27 AM | BlackRock, Inc. (Filed by)
Gilead Sciences (Subject)
| Form SCHEDULE 13G/A | |
04/16/2025
2:22 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
10:00 AM | Gilead Sciences (Subject)
Mercy Investment Services, Inc. (Filed by)
| Form PX14A6G | |
03/27/2025
3:30 PM | Gilead Sciences (Filer)
| Form DEF 14A | |
03/27/2025
3:31 PM | Gilead Sciences (Filer)
| Form DEFA14A | |
03/27/2025
3:32 PM | Gilead Sciences (Filer)
| Form ARS | |
03/20/2025
4:42 PM | Gilead Sciences (Issuer)
Wilfong Diane E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/20/2025
3:32 PM | Gilead Sciences (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
03/18/2025
3:37 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:16 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
6:08 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:12 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
6:15 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
5:41 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
5:04 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
5:10 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:42 PM | Arcus Biosciences, Inc. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:43 PM | Arcus Biosciences, Inc. (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
02/19/2025
3:43 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
8:13 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
3:22 PM | Gilead Sciences (Filed by)
Ikena Oncology, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
3:14 PM | Gilead Sciences (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/06/2025
3:24 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:11 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:09 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:15 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
4:47 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
2:31 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:18 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:46 PM | GALAPAGOS NV (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
5:33 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2025
5:38 PM | Berger Dietmar (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
7:17 PM | ASSEMBLY BIOSCIENCES, INC. (Subject)
Gilead Sciences (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
7:26 PM | ASSEMBLY BIOSCIENCES, INC. (Issuer)
Gilead Sciences (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
3:15 PM | Gilead Sciences (Filed by)
Xilio Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
12/19/2024
3:19 PM | Gilead Sciences (Reporting)
Xilio Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:27 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:22 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:08 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
12/11/2024
6:48 PM | Gilead Sciences (Issuer)
Patterson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:51 PM | Gilead Sciences (Issuer)
Telman Deborah H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:24 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:05 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:08 PM | Gilead Sciences (Issuer)
Mercier Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:13 PM | Gilead Sciences (Issuer)
O'Day Daniel Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
1:43 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:10 PM | Gilead Sciences (Issuer)
Parsey Merdad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
1:35 PM | Dickinson Andrew D (Reporting)
Gilead Sciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
